Congenital anomalies after prenatal ecstasy exposure

Lancet. 1999 Oct 23;354(9188):1441-2. doi: 10.1016/s0140-6736(99)02423-x.

Abstract

Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15.4% [95% CI 8.2-25.4]). Cardiovascular anomalies (26 per 1000 livebirths [3.0-90.0]) and musculoskeletal anomalies (38 per 1000 [8.0-109.0]) were predominant.

Publication types

  • Letter

MeSH terms

  • Abnormalities, Drug-Induced / epidemiology*
  • Abnormalities, Drug-Induced / etiology
  • Adolescent
  • Adult
  • Female
  • Hallucinogens / adverse effects*
  • Humans
  • Infant, Newborn
  • Male
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Pregnancy
  • Prospective Studies

Substances

  • Hallucinogens
  • N-Methyl-3,4-methylenedioxyamphetamine